Headlands Research CEO Mark Blumling to Speak at Milken Institute Global Conference
October 14, 2021 09:00 ET
|
Headlands Research
SAN FRANCISCO, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced that Founder and CEO...
Multi-Site Contributor Headlands Research Congratulates Biogen on FDA Approval of Aducanumab for Alzheimer’s Disease
June 16, 2021 09:00 ET
|
Headlands Research
SAN FRANCISCO, June 16, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, is pleased to have supported Biogen...
Headlands Research Accelerates Growth and Diversity Commitment with the Acquisition of Multi-Site Southern California Based Artemis Institute for Clinical Research
February 17, 2021 09:00 ET
|
Headlands Research
SAN FRANCISCO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced that it has acquired...
First Patient Dosed in AstraZeneca’s Phase III COVID-19 Vaccine Trial at Headlands’ JEM Research Institute Site in Florida
September 01, 2020 09:00 ET
|
Headlands Research
SAN FRANCISCO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Headlands Research is pleased to announce that on Friday, Aug. 28, its JEM Research Institute clinical trial site in Lake Worth, Florida,...
Multiple Headlands Research Sites Selected for AstraZeneca’s Phase III COVID-19 Vaccine Trial
August 11, 2020 09:00 ET
|
Headlands Research
SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in AstraZeneca’s upcoming Phase III COVID-19 vaccine...
Headlands Research Sites Chosen for Crucial COVID-19 Vaccine Trials
July 16, 2020 13:28 ET
|
Headlands Research
SAN FRANCISCO, July 16, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in numerous upcoming COVID-19 vaccine clinical trials....
Headlands Research Acquires CNS Global Site Leaders JEM Research Institute and Toronto Memory Program
July 07, 2020 09:00 ET
|
Headlands Research
SAN FRANCISCO, July 07, 2020 (GLOBE NEWSWIRE) -- Headlands Research, a global next-generation clinical research site organization, today announced its acquisition of two large central nervous system...